THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Lauren Dockery

Concepts (68)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Neoplasm Recurrence, Local
4
2025
330
1.430
 Why?
Ovarian Neoplasms
6
2025
595
1.290
 Why?
Uterine Cervical Neoplasms
2
2022
298
1.090
 Why?
Endometrial Neoplasms
2
2025
189
0.870
 Why?
Vulvar Neoplasms
1
2021
25
0.700
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
2
2020
37
0.700
 Why?
Carcinoma in Situ
1
2021
46
0.690
 Why?
Disease Management
1
2021
88
0.670
 Why?
Platinum Compounds
1
2019
14
0.640
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2022
411
0.580
 Why?
United States Indian Health Service
1
2018
14
0.580
 Why?
Patient Navigation
1
2018
7
0.580
 Why?
Phthalazines
1
2017
22
0.550
 Why?
Piperazines
1
2017
48
0.540
 Why?
Neoplasms, Glandular and Epithelial
1
2017
72
0.530
 Why?
Antineoplastic Agents
1
2019
678
0.430
 Why?
Indians, North American
1
2018
517
0.420
 Why?
Bevacizumab
2
2022
103
0.340
 Why?
Female
10
2025
15192
0.340
 Why?
Molecular Targeted Therapy
2
2020
135
0.300
 Why?
Aged
5
2025
5417
0.280
 Why?
Retrospective Studies
4
2024
2558
0.250
 Why?
Aged, 80 and over
3
2025
2021
0.250
 Why?
Humans
10
2025
28168
0.240
 Why?
CD47 Antigen
1
2025
4
0.230
 Why?
CD40 Antigens
1
2025
14
0.230
 Why?
Machine Learning
1
2025
85
0.220
 Why?
Neoadjuvant Therapy
1
2024
73
0.210
 Why?
Prealbumin
1
2022
4
0.200
 Why?
Endometrium
1
2022
39
0.190
 Why?
Middle Aged
4
2025
7164
0.190
 Why?
Cervix Uteri
1
2022
65
0.190
 Why?
Indoles
1
2022
99
0.180
 Why?
Vulvar Lichen Sclerosus
1
2021
1
0.180
 Why?
Vulva
1
2021
5
0.180
 Why?
Papillomaviridae
1
2021
88
0.170
 Why?
Indazoles
1
2020
18
0.170
 Why?
Fallopian Tube Neoplasms
1
2020
52
0.160
 Why?
Piperidines
1
2020
48
0.160
 Why?
Peritoneal Neoplasms
1
2020
79
0.160
 Why?
Papillomavirus Infections
1
2021
144
0.150
 Why?
Adult
3
2025
7765
0.150
 Why?
Disease-Free Survival
1
2019
238
0.150
 Why?
Clinical Trials, Phase II as Topic
1
2017
25
0.140
 Why?
Patient Compliance
1
2018
76
0.140
 Why?
Clinical Trials, Phase I as Topic
1
2017
27
0.140
 Why?
Disease Progression
1
2019
474
0.140
 Why?
Treatment Outcome
2
2020
2384
0.130
 Why?
Randomized Controlled Trials as Topic
1
2017
386
0.120
 Why?
Risk Factors
1
2021
2087
0.120
 Why?
Age Factors
1
2017
733
0.120
 Why?
Prospective Studies
1
2017
1257
0.110
 Why?
United States
1
2018
2151
0.090
 Why?
Young Adult
1
2018
2738
0.090
 Why?
Adolescent
1
2018
3128
0.080
 Why?
Immunoglobulin Fc Fragments
1
2025
4
0.060
 Why?
Recombinant Fusion Proteins
1
2025
233
0.050
 Why?
Drug Resistance, Neoplasm
1
2025
167
0.050
 Why?
Interleukin-8
1
2022
45
0.050
 Why?
Cytoreduction Surgical Procedures
1
2022
33
0.050
 Why?
Vitamin D
1
2022
50
0.050
 Why?
Predictive Value of Tests
1
2024
475
0.050
 Why?
Chemotherapy, Adjuvant
1
2022
114
0.050
 Why?
Interleukin-6
1
2022
194
0.040
 Why?
Pilot Projects
1
2022
436
0.040
 Why?
Biomarkers
1
2022
763
0.040
 Why?
Postoperative Complications
1
2022
613
0.040
 Why?
Prognosis
1
2020
803
0.040
 Why?
Dockery's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (68)
Explore
_
Co-Authors (18)
Explore
_
Similar People (59)
Explore
_
Same Department Expand Description
Explore
_

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES